Breaking News Instant updates and real-time market news.

VNTR

Venator Materials

$5.06

0.28 (5.86%)

, TROX

Tronox

$10.83

0.46 (4.44%)

16:29
05/14/19
05/14
16:29
05/14/19
16:29

Venator Materials begins lawsuit against Tronox

Venator Materials (VNTR) announced it has commenced a lawsuit in Delaware Superior Court against Tronox (TROX). In the lawsuit, which arises from Tronox's refusal to honor its contract to pay a $75M "Break Fee" to Venator upon conditions which have now been met, Venator seeks a judgment for $75M, plus pre- and post-judgment interest, and its reasonable attorneys' fees and costs.

VNTR

Venator Materials

$5.06

0.28 (5.86%)

TROX

Tronox

$10.83

0.46 (4.44%)

  • 30

    May

VNTR Venator Materials
$5.06

0.28 (5.86%)

02/06/19
UBSW
02/06/19
UPGRADE
Target $7
UBSW
Buy
UBS upgrades Venator to Buy ahead of mid-year earnings 'inflection'
UBS analyst John Roberts upgraded Venator Materials to Buy from Neutral with an unchanged price target of $7. The analyst sees a three-to-one upside/downside ratio for the stock following the 50% drop in the past quarter and 80% decline in the past year. He expects pigment volume declines into the channel to abate before mid-2019, followed by a recovery. He also Venator's thinks margin pressure from lower TiO2 prices and higher ore costs will stabilize in mid-2019, "leading to a mid-year inflection in earnings."
04/18/19
RBCM
04/18/19
UPGRADE
RBCM
Outperform
Venator Materials upgraded to Outperform from Sector Perform at RBC Capital
04/18/19
04/18/19
UPGRADE
Target $9

Outperform
Venator Materials upgraded to Outperform at RBC Capital on improving TiO2 cycle
As previously reported, RBC Capital analyst Arun Viswanathan upgraded Venator Materials to Outperform from Sector Perform and raised his price target to $9 from $7. The analyst believes that the titanium dioxide "cycle is turning", with destocking activity nearing completion amid improving global demand and pricing. Viswanathan maintains his FY19 and FY20 EPS estimates, but lifts his target multiple to 6.5-times from 5.5-times earnings to reflect the sentiment, even though he cautions investors about Venator Materials being a "high risk/high reward stock."
04/18/19
04/18/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. PepsiCo (PEP) upgraded to Neutral from Sell at Goldman Sachs with analyst Judy Hong citing its "strong" Q1 results that saw organic revenue accelerate to 5% and gross margins top expectations. 2. J.M. Smucker (SJM) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Pamela Kaufman saying she believes the company's reinvestment strategy will drive improved topline momentum across its key segments and should allow the company to return to positive organic growth in FY20. 3. Venator Materials (VNTR) upgraded to Outperform from Sector Perform at RBC Capital with analyst Arun Viswanathan saying he believes that the titanium dioxide "cycle is turning", with destocking activity nearing completion amid improving global demand and pricing. 4. Ecolab (ECL) upgraded to Buy from Neutral at Nomura Instinet with analyst Dan Dolev saying with the problematic energy business soon to be spun-off, Ecolab's "recession resistant qualities should stand out, warranting a significant premium to peers." 5. Qualcomm (QCOM) upgraded to Buy from Hold at DZ Bank. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
TROX Tronox
$10.83

0.46 (4.44%)

03/20/19
BMOC
03/20/19
NO CHANGE
Target $19
BMOC
Outperform
Tronox price target raised to $19 from $13 at BMO Capital
BMO Capital analyst John McNulty raised his price target on Tronox to $19 and kept his Outperform rating after the company and regulators moved to put the Cristal transaction for FTC consideration. The analyst states that while the support from the FTC staff does not necessarily guarantee the approval of the Ashtabula sale remedy by the deciding commission, it "dramatically increases the likelihood" of success, and believes that the transaction could close next month. McNulty also sees Tronox as more vertically integrated after the Cristal transaction, forecasting "significant upside" potential for the stock.
04/11/19
JPMS
04/11/19
NO CHANGE
Target $17
JPMS
Overweight
Tronox shares 'have room' to rally to $17 near-term, says JPMorgan
Tronox shares, following completion of the Cristal acquisition, "have room" to appreciate shorter-term to reach $17, and the appreciation "will occur in steps," JPMorgan analyst Jeffrey Zekauskas tells investors in a research note. He keeps an Overweight rating on Tronox with a $17 December 2019 price objective. Exxaro owns 28.7M Tronox shares that it intends to monetize and some investors believe these shares have created an "overhang," Zekauskas writes. However, he believes Tronox will repurchase theses shares as well as Exxaro's 26% stake in Tronox's South African joint ventures. The analyst also believes that the major titanium dioxide companies "should begin to experience a healthy demand pattern" in the second half of 2019. Zekauskas expects Tronox to generate $3.00 per share in free cash flow in 2020.
04/11/19
RHCO
04/11/19
NO CHANGE
Target $20
RHCO
Buy
Tronox price target raised to $20 from $17 at SunTrust
SunTrust analyst James Sheehan raised his price target on Tronox to $20 and kept his Buy rating, saying the company's settlement of an antitrust suit involving the proposed Cristal merger is a positive catalyst for the whole titanium dioxide group. The analyst expects Tronox to be the "largest beneficiary" of the settlement and sees the deal closing as imminent. Sheehan adds that the company's expected $700M in proceeds from the sale of its North American TiO2business to INEOS Enterprises should be used for share repurchases.
05/06/19
JPMS
05/06/19
DOWNGRADE
Target $34
JPMS
Neutral
JPMorgan downgrades Chemours to Neutral, prefers shares of Tronox
JPMorgan analyst Jeffrey Zekauskas downgraded Chemours (CC) to Neutral from Overweight and lowered his price target for the shares to $34 from $40. The company's Q1 volumes decreased 35% year-over-year, which might be expected in a recession "but it is not any kind of normal result in a growing economy," Zekauskas tells investors in a research note. The analyst decreased his EBITDA expectations, which brought his price target to $34, near the current Chemours share price. He prefers shares of Tronox (TROX) to Chemours.

TODAY'S FREE FLY STORIES

CMG

Chipotle

$664.67

-41.38 (-5.86%)

, BLMN

Bloomin' Brands

$18.65

-1.55 (-7.67%)

11:31
05/23/19
05/23
11:31
05/23/19
11:31
On The Fly
Downgrades of Chipotle, Qualcomm headline today's top analyst calls »

Check out today's top…

CMG

Chipotle

$664.67

-41.38 (-5.86%)

BLMN

Bloomin' Brands

$18.65

-1.55 (-7.67%)

QCOM

Qualcomm

$67.38

-1.86 (-2.69%)

TGT

Target

$78.84

1.34 (1.73%)

AMZN

Amazon.com

$1,823.68

-34.06 (-1.83%)

WMT

Walmart

$101.31

-0.73 (-0.72%)

BKNG

Booking Holdings

$1,724.04

-21.46 (-1.23%)

EXPE

Expedia

$116.92

0.15 (0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

  • 03

    Jun

  • 04

    Jun

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 07

    Jun

  • 07

    Jun

  • 12

    Jun

  • 18

    Jun

  • 24

    Jun

  • 25

    Jun

  • 27

    Jun

  • 09

    Jul

  • 31

    Jul

  • 15

    Aug

  • 13

    Nov

GE

General Electric

$9.62

-0.28 (-2.83%)

11:30
05/23/19
05/23
11:30
05/23/19
11:30
Options
Giant ratio spread in GE as shares drop 2.1% »

Giant ratio spread in GE…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

11:25
05/23/19
05/23
11:25
05/23/19
11:25
General news
Treasury announced $113 B in shorter coupons for auction »

Treasury announced $113 B…

11:25
05/23/19
05/23
11:25
05/23/19
11:25
Conference/Events
Stephens medical devices analyst to hold a group luncheon »

Medical Devices &…

ECA

Encana

$6.05

-0.435 (-6.71%)

11:20
05/23/19
05/23
11:20
05/23/19
11:20
Options
Notable call buy in Encana as shares dip »

Notable call buy in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTOO

T2 Biosystems

$1.88

-0.685 (-26.76%)

11:19
05/23/19
05/23
11:19
05/23/19
11:19
Hot Stocks
T2 Biosystems highlights clinical data at ECCMID, MAD-ID meetings »

T2 Biosystems highlighted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jun

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
05/23/19
05/23
11:17
05/23/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
05/23/19
05/23
11:16
05/23/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
05/23/19
05/23
11:15
05/23/19
11:15
General news
Breaking General news story  »

8-Week Bill Auction to be…

11:15
05/23/19
05/23
11:15
05/23/19
11:15
General news
Breaking General news story  »

4-Week Bill Auction to be…

MICT

Micronet Enertec

$0.99

(0.00%)

11:10
05/23/19
05/23
11:10
05/23/19
11:10
Hot Stocks
Micronet Enertec receives two orders totaling $1.3M for SmartHub platform »

MICT announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQT

EQT Corporation

$19.64

-0.31 (-1.55%)

11:10
05/23/19
05/23
11:10
05/23/19
11:10
Hot Stocks
EQT Corporation files definitive proxy, mails letter to shareholders »

EQT Corporation announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HTHT

Huazhu Group

$32.60

-1.81 (-5.26%)

11:10
05/23/19
05/23
11:10
05/23/19
11:10
Downgrade
Huazhu Group rating change  »

Huazhu Group downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

USO

United States Oil Fund

$12.09

-0.66 (-5.18%)

11:10
05/23/19
05/23
11:10
05/23/19
11:10
Options
Customer rolls US Oil ETF puts for 233% gain as oil sells off »

Customer rolls US Oil ETF…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTLR

Rattler Midstream

$0.00

(0.00%)

, FANG

Diamondback Energy

$104.01

-4.86 (-4.46%)

11:09
05/23/19
05/23
11:09
05/23/19
11:09
Syndicate
Rattler Midstream opens at $18.06, IPO priced at $17.50 per share »

Rattler Midstream (RTLR)…

RTLR

Rattler Midstream

$0.00

(0.00%)

FANG

Diamondback Energy

$104.01

-4.86 (-4.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

  • 23

    May

FCX

Freeport McMoRan

$9.94

-0.11 (-1.09%)

11:05
05/23/19
05/23
11:05
05/23/19
11:05
Options
Freeport McMoRan call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

IBM

IBM

$132.49

-3.53 (-2.60%)

11:04
05/23/19
05/23
11:04
05/23/19
11:04
Hot Stocks
ProcessMap, IBM announce joint initiative to develop IoT solutions »

ProcessMAP and IBM…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

11:04
05/23/19
05/23
11:04
05/23/19
11:04
General news
Kansas City Fed Manufacturing Index Level data reported »

May Kansas City Fed…

LB

L Brands

$24.88

0.59 (2.43%)

10:59
05/23/19
05/23
10:59
05/23/19
10:59
On The Fly
Analysts remain cautious on L Brands despite stronger quarter »

Shares of L Brands (LB)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 22

    Aug

IDYA

IDEAYA Biosciences

$0.00

(0.00%)

10:57
05/23/19
05/23
10:57
05/23/19
10:57
Syndicate
Breaking Syndicate news story on IDEAYA Biosciences »

IDEAYA Biosciences opens…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

CNX

CNX Resources

$7.56

-0.26 (-3.32%)

10:50
05/23/19
05/23
10:50
05/23/19
10:50
Options
Size put option block in CNX after calls bought yesterday »

Size put option block in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

10:50
05/23/19
05/23
10:50
05/23/19
10:50
General news
Treasury Action: yields have extended lower as Wall Street sinks »

Treasury Action: yields…

AZZ

AZZ Inc.

$43.62

(0.00%)

10:46
05/23/19
05/23
10:46
05/23/19
10:46
Hot Stocks
AZZ Inc. discloses change in independent registered public accounting firm »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSK

GlaxoSmithKline

$39.97

-0.22 (-0.55%)

10:45
05/23/19
05/23
10:45
05/23/19
10:45
Hot Stocks
GSK to change sales representative incentive program »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

10:45
05/23/19
05/23
10:45
05/23/19
10:45
General news
he April U.S. new home sales report beat estimates »

The April U.S. new home…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.